ClinicalTrials.gg
RecruitingNCT06119698iHOPEUpdated Nov 18, 2025

Improving Health for Older Adults With Pain Through Engagement

An interventional study of GetActive+ in Chronic Pain and Musculoskeletal Pain, sponsored by Massachusetts General Hospital. Recruiting at 1 site in United States. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2025-11-18.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2024; still recruiting 2 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
55 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Chronic Pain by Massachusetts General Hospital — 7 open to participants now, 8 under way, none of them phase 3. Chronic Pain · Massachusetts General Hospital.

Planned enrollment
3rd of 23
200 · median 60
Started
2024
with 2 others
No phase
20 of 27
5 open now
Registered
20th of 27
by date

Among the 27 studies in Chronic Pain by Massachusetts General Hospital, this one is the 3rd largest by planned enrollment of the 23 interventional ones that give a count, is one of 3 that started in 2024, is one of 20 with no phase, and was the 20th registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

7 of the 27 studies in Chronic Pain by Massachusetts General Hospital are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 55 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Chronic Pain by Massachusetts General Hospital, or all of them as a file.
02

Study summary

The goal of this project is to conduct a randomized, hybrid type 1 effectiveness-implementation trial (N=200) to evaluate the effectiveness and implementation of a 10-week mind-body and walking program (GetActive+) vs treatment as usual (TAU). The investigators will test for improvements in self-reported, performance-based (i.e., six-minute walk test), and objective (i.e., step-count) physical function, emotional function, as well as feasibility, acceptability and implementation markers. Participants will complete measures at baseline (0 weeks), post-intervention (1 week after intervention completion), and 6-month follow-up.

This study will receive support from and inclusion in the HEAL Initiative (https://heal.nih.gov/).

Read the detailed description

The aim of this phase is to conduct a randomized, hybrid type 1 effectiveness-implementation trial (N=200) to evaluate the effectiveness and implementation of GetActive+ vs TAU on the following outcomes.

Aim 1: Self-reported physical function at 10 weeks (primary). Aim 2: Self-reported physical function at 6 months, performance based (6-minute walk test), and objective (step-count) physical function, as well as self-reported emotional function, pain, social support and loneliness at 10 weeks and 6 months.

Aim 3: Feasibility, acceptability, fidelity and adoption at patient, provider, and organization levels based on Proctor's implementation framework.

The investigators will enroll N=200 older adults with chronic pain from Revere HealthCare Center and MGH Broadway Primary Care in Revere. The GetActive+ program used in the Randomized Controlled Trial (RCT) will incorporate mind-body skills, cognitive behavioral and physical restoration skills (e.g., quota-based pacing) to help individuals increase self-reported, performance based and objective (step count) physical function. This program will teach participants four core skills: 1) weekly goal setting for gradual increase in time spent walking paired with activities of daily living that are meaningful and important to participants (i.e. walk instead of drive to the store; walk to the park with kids); 2) quota-based pacing (increasing walking goal gradually non-contingent of pain); 3) mind-body skills (e.g., diaphragmatic breathing to manage intense pain flares and pain anxiety; progressive muscle relaxation to increase body awareness and reduce reactivity to pain sensations; mindfulness exercises to understand the transience of pain and change one's relationship with it; self-compassion when falling short of set goals); and 4) understand the downward spiral (e.g. how reducing activity perpetuates pain and disability), correct myths about pain or unhelpful pain-related thoughts that interfere with meeting program goals. Participants will be encouraged to complete their homework (logs for mind-body practice, physical activities) each day. Participants will be given the option to receive homework and session reminders via text messages from study staff. This between-session contact will focus on increasing treatment adherence, maintaining engagement, and session reminders. The investigators will run groups primarily in English with additional groups in Spanish.

Baseline assessments, post-intervention assessments and 6-month follow up assessments will include the 6MWT, objective step count via ActiGraph, and self-reported measures including physical function, emotional function, pain, social support, and loneliness while accounting for clinical, demographic, and social determinants of health.

03

Conditions studied

  • Chronic Pain
  • Musculoskeletal Pain

Keywords

  • Older adults
  • Mind-body intervention
  • Chronic pain
  • ActiGraph
  • Community health center
  • Physical function
04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Older Adults (i.e., age >=55)
  2. Diagnosed musculoskeletal chronic pain of any type (e.g., pain > 3 months)
  3. Pain score >=4 (moderate) on the Numerical Rating Scale
  4. Cognitively able to participate as measured by the Short Portable Mental Health questionnaires (e.g., \<4 errors)
  5. Self-reported ability to complete the 6-minute walk test including with assistive devices
  6. Patient at Revere HealthCare Center or MGH Broadway Primary Care in Revere who is cleared for participation by medical staff
  7. English or Spanish fluency and literacy

Exclusion criteria

Exclusion Criteria:

  1. Current serious medical illness that is expected to worsen in the next 6 months (e.g., cancer)
  2. Individuals who are unwilling or unable to comply with study procedures including wearing a smartwatch
  3. Active suicidal ideation with plan or intent
  4. Active and untreated serious mental health or substance use disorder
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    GetActive+

    A mind-body program focused on increasing physical and emotional function in older adults with chronic musculoskeletal pain

    Behavioral: GetActive+

  • No intervention
    Treatment as usual

    Treatment as Usual (TAU) includes traditional primary care management of chronic pain.

Interventions

  • BehavioralGetActive+

    This is a 10-week group mind body program focused on improving self-reported physical activity, performance-based physical activity, and ambulatory step count by combining mind body skills tailored for individuals with chronic pain, with gradual increase in walking using quota based pacing and goal setting, adapted specifically for older adults from a medically underserved location.

06

What researchers measure

Primary outcomes

  1. Physical function - self-report

    Patient-Reported Outcomes Measurement Information System (PROMIS) v2.0 Physical Functioning Short Form 6b; assesses ability to carry out activities that require physical actions, ranging from self-care to work. Scores range from 6 to 30, with higher scores indicating greater physical function.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total) - Measure time point of 10 weeks is considered for primary outcome.

Secondary outcomes

  1. Physical function - objective

    Average step count with wrist-worn ActiGraph wGT3X-BT; collects average step count for 4-7 days.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  2. Physical function - performance-based

    6-minute walk test (6MWT); measures the total distance in meters covered by an individual in 6 minutes, with greater distances covered indicating better physical function.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  3. Pain Intensity and Severity

    Brief Pain Inventory - Short Form (BPI-SF); assesses pain severity and interference. Scores range from 0 to 10, with higher scores indicating more severe pain severity or interference.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  4. Pain Intensity and Interference

    Pain, Enjoyment of Life and General Activity (PEG) Scale; measures pain intensity and pain interference in the enjoyment of life and activities of daily living. Scores range from 0 to 10, with higher scores indicating more severe pain and related interference.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  5. Depression

    Patient Health Questionnaire - 8 (PHQ-8); assesses depressive symptoms. Scores range from 0 to 24, with higher scores indicating more severe depressive symptoms.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  6. Anxiety

    Generalized Anxiety Disorder - 7 (GAD-7); measures anxiety symptoms. Scores range from 0 to 21, with higher scores indicating greater anxiety.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  7. Impression of Change

    Patient Global Impression of Change (PGIC); assesses subjective changes in response to the intervention. Scores range from 0 to 6, with higher scores indicating worse outcomes.

    Time frame: Post-Intervention

Other outcomes

  1. Quota-based Pacing

    4-item subsection of the Activity Pacing Questionnaire; measures ability to pace. Scores range from 4 to 20, with higher scores indicating increased quota-based pacing.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  2. Pain Catastrophizing

    Pain Catastrophizing Scale (PCS); assesses magnification, helplessness, and rumination associated with the ability to cope with pain. Scores range from 0 to 52, with higher scores indicating increased pain catastrophizing.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  3. Mindfulness

    Applied Mindfulness Process Scale (AMPS); assesses mindfulness use in daily life. Scores range from 0 to 60, with higher scores indicating greater utilization of mindfulness.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  4. Current Status

    Measure of Current Status (MOCS); assesses healthy coping skills. Scores range from 0 to 52, with higher scores reflecting a stronger ability to recognize and cope with stress.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  5. Self-Compassion

    Self-Compassion Scale - Short Form (SCS-SF); assesses the ability to practice self-compassion. Scores range from 1 to 5, with higher scores associated with lower levels of self-compassion.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  6. Social Support

    Interpersonal Support Evaluation List - 12 (ISEL-12); measures perceptions of social support. Scores range from 12 to 48, with higher scores indicating stronger social support.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  7. Loneliness

    University of California Los Angeles - 3 Loneliness Scale (UCLA-3); measures loneliness in relational connectedness, social connectedness, and social isolation. Scores range from 3 to 9, with higher scores indicating greater social isolation.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  8. Fear of Pain

    Tampa Scale for Kinesiophobia - 11 (TSK-11); assesses fear of pain and activities that cause pain. Scores range from 11 to 44, with higher scores reflecting more severe kinesiophobia.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  9. Self-Efficacy for Exercise

    Self-Efficacy for Exercise (SEE); assesses an individual's beliefs in their ability to exercise three times per week for 20 minutes. Scores range from 0 to 90, with higher scores indicating higher confidence in exercising despite barriers.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  10. Post Traumatic Stress Disorder

    Abbreviated Post-Traumatic Checklist-Civilian Version (PCL-C-6); assess current Post Traumatic Stress Disorder (PTSD) symptoms. Scores range from 6 to 30, with higher scores being suggestive of greater difficulties with post-traumatic stress.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  11. Discrimination

    Everyday Discrimination Scale - Short Version (EDS-S); assesses experiences of daily discrimination against minority populations. Scores range from 0 to 25, with higher scores indicating greater frequency of discriminatory experiences.

    Time frame: Baseline

  12. Stress

    Perceived Stress Scale - 4 (PSS-4); assesses stress perception levels. Scores range from 0 to 16, with higher scores indicating more severe stress.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  13. Substance Use

    Tobacco, Alcohol, Prescription medications, and other Substance use (TAPS); assess substance use behaviors. Each substance is scored individually from 0 to 4, with lower scores indicating more problematic substance use behaviors.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  14. Sleep Duration

    1-item of the Pittsburgh Sleep Quality Index (PSQI); assesses average sleep duration per night in the past month.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  15. Sleep Disturbance

    PROMIS v1.0 Sleep Disturbance - Short Form 6a; assesses duration and quality of sleep. Scores range from 6 to 30, with greater scores indicating higher sleep quality and more sleep disturbance.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

  16. Quality of Life Assessment

    World Health Organization Quality of Life - 2 (WHOQOL-2); assesses satisfaction with health and quality of life. Scores range from 2 to 10, with higher scores indicating greater quality of life.

    Time frame: Baseline, Post-Intervention, 6-Month Follow Up (~9 months total)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Greenberg J, Lin A, Popok PJ, Kulich RJ, Edwards RR, Vranceanu AM. Getting Active Mindfully: Rationale and Case Illustration of a Group Mind-body and Activity Program for Chronic Pain. J Clin Psychol Med Settings. 2021 Dec;28(4):706-719. doi: 10.1007/s10880-020-09758-w. Epub 2021 Jan 19. PubMed 33469845 ↗
  • Grunberg VA, Greenberg J, Mace RA, Bakhshaie J, Choi KW, Vranceanu AM. Fitbit Activity, Quota-Based Pacing, and Physical and Emotional Functioning Among Adults With Chronic Pain. J Pain. 2022 Nov;23(11):1933-1944. doi: 10.1016/j.jpain.2022.07.003. Epub 2022 Jul 29. PubMed 35914640 ↗
  • Popok PJ, Greenberg J, Gates MV, Vranceanu AM. A qualitative investigation of activity measurement and change following a mind-body activity program for chronic pain. Complement Ther Clin Pract. 2021 Aug;44:101410. doi: 10.1016/j.ctcp.2021.101410. Epub 2021 May 2. PubMed 33971485 ↗
  • Vonderheide C, Kilduff C, McDermott KA, Greenberg J, La Camera DE, Giraldo-Santiago N, Kurkul A, Alvarez-Frank N, Kim Y, Pasinski R, Gholston M; iHOPE Study Team; Ritchie CS, Vranceanu AM. Protocol for a hybrid type 1 effectiveness-implementation trial of a mind-body activity program for older adults with chronic pain in a medically underserved area: The iHOPE study. Contemp Clin Trials. 2025 Dec;159:108116. doi: 10.1016/j.cct.2025.108116. Epub 2025 Oct 24. PubMed 41326265 ↗

Individual participant data

Plan to share: Yes — Data file (e.g., blinded Excel with raw scores at each time point) Data dictionary Detailed protocol Analysis plan

Supporting information: Study protocol, Statistical analysis plan

Time frame: Information is anticipated to be available 6 months after completion of the study.

Access criteria: Data can be accessed in the Vivli data repository; no specialized tools will be need to view the data other than what is noted on the Vivli website. See above for details on what will be available to access.

Data sharing details ↗ · www.vivli.org

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2024 (actual). Primary completion is estimated for Apr 2027, 30 months after the start.

Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 30 months is above that.

Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 17, 2023
First posted
Nov 7, 2023
StartActual
Oct 1, 2024
Primary completionEst.
Apr 1, 2027
CompletionEst.
Jul 2027
Last update
Nov 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06119698
Responsible party
Ana-Maria Vranceanu, PhD (Principal Investigator, Massachusetts General Hospital) — Principal investigator
First posted
Nov 7, 2023
Start date
Oct 1, 2024
Primary completion
Apr 1, 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Nov 18, 2025

Study contacts

Ana-Maria Vranceanu, PhD
Contact
avranceanu@mgh.harvard.edu
617-724-4977
Christine Ritchie, MD, MPH
Contact
csritchie@mgh.harvard.edu,
617-726-1382
Ana-Maria Vranceanu, PhD
principal investigator · Massachusetts General Hospital
Christine Ritchie, MD, MPH
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion